Skip to content

To observe the clinical effect of adductor canal block with different volumes of ropivacaine for postoperative analgesia in patients undergoing high tibial osteotomy

To observe the clinical effect of adductor canal block with different volumes of ropivacaine for postoperative analgesia in patients undergoing high tibial osteotomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100223
Enrollment
Unknown
Registered
2025-04-07
Start date
2025-04-07
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Tibial Osteotomy

Interventions

R1 group (0.25% ropivacaine):0.25%Ropivacaine Adductor Canal Block
R2 group (0.5% ropivacaine):0.5%Ropivacaine Adductor Canal Block

Sponsors

The Second Affiliated Hospital of Xi'an Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) American Association of Anesthesiologists (ASA) Physical Condition I, II and III (2) Age >18 years old, expected hospitalization for one week or more (3) No cognitive dysfunction (4) The patient agreed to cooperate with the investigation and research (5) Patients who need to undergo high-level osteotomy of the tibia in our hospital

Exclusion criteria

Exclusion criteria: (1) Refuse to sign the informed consent form, unable to understand or participate in data collection (2) Those who have a history of lumbar disease or surgery and cannot be anesthetized with a hard waist (3) Intolerant or contraindications to known local anesthetics, non-steroidal anti-inflammatory drugs or opioids (4) People with coagulation dysfunction, heart, brain, liver, kidney and other organ failure

Design outcomes

Primary

MeasureTime frame
Postoperative analgesia duration;

Countries

China

Contacts

Public ContactGao Yuanyuan

The Second Affiliated Hospital of Xi'an Medical College

573176457@qq.com+86 181 9103 1315

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026